US Patent 8758299 Intradermal injector
Patent 8758299 was granted and assigned to Antares Pharma Inc. on June, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08758299 Intradermal injector US Patent 8758299 Intradermal injector
Infobox
Patent Number
0875829900
Patent Number
875829900
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
087582990
Date of Patent
June 24, 2014
0Patent Application Number
138574380
Date Filed
April 5, 2013
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
087582990
Date of Patent
June 24, 2014
0Patent Application Number
138574380
Date Filed
April 5, 2013
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08758299 Intradermal injector
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08758299
Date of patent
June 24, 2014
Patent application number
13857438
Date Filed
April 5, 2013
Patent primary examiner
Find more entities like US Patent 8758299 Intradermal injector
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
